5-year FFS | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
BAX cutoff | % of HD BAX positive | ABVD or equivalent^{a} (n = 116) | NOVP plus radiotherapy (n = 79) | MOPP (n = 26) | Radiotherapy alone (n = 29) | |||||
20% | 84 | 85 vs. 89^{b} | 79 vs. 75 | 75 vs. 100 | 76 vs. 75 | |||||
P = 0.74 | P = 0.9 | P = 0.54 | P = 0.96 | |||||||
30% | 77 | 84 vs. 92 | 79 vs. 75 | 72 vs. 67 | 74 vs. 83 | |||||
P = 0.35 | P = 0.86 | P = 0.7 | P = 0.63 | |||||||
50% | 64 | 83 vs. 93 | 78 vs. 79 | 71 vs. 81 | 72 vs. 82 | |||||
P = 0.19 | P = 0.45 | P = 0.6 | P = 0.57 | |||||||
75% | 34 | 86 vs. 86 | 81 vs. 77 | 60 vs. 81 | 83 vs. 74 | |||||
P = 0.97 | P = 0.7 | P = 0.48 | P = 0.66 |
^{a} The first value in each column is the FFS of patients with BAX-positive HRS cells greater than the cutoff, and the second is patients with BAX-positive HRS cells less than or equal to the cutoff.
^{b} Log-rank (Mantel-Cox) Ps were used for all statistical comparisons.